|
Delayed
OTC Markets
20:42:43 11/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 4.070 USD | +1.75% |
|
+4.36% | -1.63% |
| 10-29 | Hypera S.A., Q3 2026 Earnings Call, Oct 28, 2026 | |
| 10-28 | Hypera S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HYPERA S.A. | Other Pharmaceuticals | +1.75% | +4.36% | -1.63% | -17.44% | -23.52% | 2.78B |
-
|
-
|
-
|
- Stock Market
- Stocks
- HYPE3 Stock
- HYPMY Stock
- Charts Hypera S.A.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
